NeuroPsychoPharmacologie

mardi 14 juin 2022
Sessions parallèles
Sessions parallèles S14 16h30 > 18h00 NeuroPsychoPharmacologie Salle des Thèses Sessions parallèles

Modérateurs : Luc ZIMMER (Lyon), David DEVOS (Lille)

Conférence invitée
16h30 A new way for drug development in neuropsychopharmacology - Michael SPEDDING, IUPHAR (Paris)

Communications libres

CO-019 CO-019 - The ERICH3 rs11580409 polymorphism is associated with 6-month antidepressant response in a cohort of depressed patients > K. Kenneth Chappell CO-020 CO-020 - Plasma acetyl-L-carnitine and L-carnitine in major depressive episodes: a case-control study before and after treatment > A. Abd El Kader AIT TAYEB CO-021 CO-021 - Plasma concentration of delta9-tetrahydrocannabinol (THC) and its metabolites and clinical features observed after accidental exposure to cannabis in infants and young children: French addictovigilance data > C. Camille PONTE CO-022 CO-022 - Does concomitant ethanol and diazepam use modulate age-related cognitive decline? > L. Louise CARTON CO-023 CO-023 - Positive perception of a regulation is associated with a change in practice: the example of zolpidem prescription after its new regulation among French general practitioners > E-J. Edouard-Jules Laforgue CO-024 CO-024 - fMRI exploration of a biased agonist of 5-HT1A receptors to treat levodopa-induced dyskinesia in hemiparkinsonian rats > S. Sarah Chaib

Copyright © key4events - All rights reserved